Tesamorelin vs Thymosin Beta-4

FDA Approved vs Well Studied
synergistic Mechanism-based · 47% Tesamorelin and Thymosin Beta-4 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Molecular Data

Tesamorelin Thymosin Beta-4
Weight 5,135.9 Da 4,963.44 Da
Half-life 26-38 minutes Dose-dependent; relatively short (exact values not established)
Chain 44 amino acids 43 amino acids
Type GHRH analog Thymosin peptide

Key Benefits

Tesamorelin
01 FDA-approved formulation
02 Selective visceral fat targeting (15-20% reduction)
03 Proven clinical efficacy
04 Standardized dosing
05 37% liver fat reduction in NAFLD
06 Preserved subcutaneous fat
Thymosin Beta-4
01 Systemic regenerative effects
02 Proven clinical efficacy
03 Optimal bioavailability for tissue repair
04 Promotes angiogenesis
05 Reduces inflammation

Dosing Protocols

Tesamorelin
1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) / Once daily (evening preferred for GH rhythm)
HIV Lipodystrophy (FDA-approved) 1.4mg Once daily
Visceral Fat Reduction 2mg Once daily
Anti-aging/Body Composition 1-2mg 5-7x weekly
NAFLD Treatment 2mg Once daily (12 months)
Cognitive Enhancement 1mg Once daily (20 weeks)
Thymosin Beta-4
2-6mg per injection (varies by protocol and severity) / Daily for acute healing, 2x weekly for maintenance/chronic conditions
Acute Wound Healing 1.6mg Daily
Cardiac Protection 42mg Single dose
Chronic Tissue Repair 6mg Twice weekly
Neurological Recovery 30mg Three times over 72 hours
General Regeneration 2-5mg Daily or every other day

Side Effects

Tesamorelin
Injection site reactions (17%)
Joint pain (13%)
Water retention
Thymosin Beta-4
Mild injection site reactions
Local inflammation at injection sites
Contraindications
Active malignancy
Pituitary disorders
Pregnancy
Active chemotherapy treatment
Severe systemic allergies to peptides

Research Evidence

Tesamorelin Thymosin Beta-4
Status FDA Approved Well Studied
References 5 studies 4 studies
Latest June 2025
FDA Approved Yes No

This comparison is for educational and research purposes only. Consult a healthcare professional before use.